current affair

The phase 3 clinical trial was jointly initiated by ICMR and Bharat Biotech International Limited in mid-November 2020. The trial has been conducted on a total of 25,800 individuals across 21 sites.

from Jagran Josh https://ift.tt/309DutU
via IFTTT